Self-Reported Nonadherence to Medication Is Not Associated with Health-Related Quality of Life in Parkinson’s Disease

Nonadherence is a growing issue in the treatment of Parkinson’s disease (PD). Many factors are known to influence nonadherence, but little is known about the influence of quality of life (QoL). Detailed clinical data were obtained from 164 patients with PD using the Parkinson’s Disease Questionnaire...

Full description

Bibliographic Details
Main Authors: Hannah M. Zipprich, Sarah Mendorf, Thomas Lehmann, Tino Prell
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/11/2/273
_version_ 1797395615056920576
author Hannah M. Zipprich
Sarah Mendorf
Thomas Lehmann
Tino Prell
author_facet Hannah M. Zipprich
Sarah Mendorf
Thomas Lehmann
Tino Prell
author_sort Hannah M. Zipprich
collection DOAJ
description Nonadherence is a growing issue in the treatment of Parkinson’s disease (PD). Many factors are known to influence nonadherence, but little is known about the influence of quality of life (QoL). Detailed clinical data were obtained from 164 patients with PD using the Parkinson’s Disease Questionnaire-39 (PDQ-39) and the German Stendal Adherence with Medication Score (SAMS). Descriptive statistics were used to identify reasons for nonadherence, and multivariable linear models were used to study associations between QoL and clinical parameters as well as nonadherence. Multivariate analysis of variance (MANOVA) and multivariate analysis of covariance (MANCOVA) were used to study the effect of the SAMS on PDQ domains and other medical covariates. The results showed that 10.4% (<i>n</i> = 17) of patients were fully adherent, 66.4% (<i>n</i> = 109) were moderately nonadherent, and 23.2% (<i>n</i> = 38) were nonadherent. Nonadherence was associated with male gender, lower Montreal Cognitive Assessment (MoCA) score, higher non-motor symptoms questionnaire (NMS-Quest) score, greater number of medications per day (an indicator of comorbidity), and higher Beck Depression Inventory (BDI) score. QoL was correlated with male gender, lower MoCA score, higher NMS-Quest score, more comorbidities, and higher BDI score, but was not correlated with nonadherence.
first_indexed 2024-03-09T00:38:02Z
format Article
id doaj.art-0101c7fbf5ac4a50814b823efbc43815
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-09T00:38:02Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-0101c7fbf5ac4a50814b823efbc438152023-12-11T17:59:17ZengMDPI AGBrain Sciences2076-34252021-02-0111227310.3390/brainsci11020273Self-Reported Nonadherence to Medication Is Not Associated with Health-Related Quality of Life in Parkinson’s DiseaseHannah M. Zipprich0Sarah Mendorf1Thomas Lehmann2Tino Prell3Department of Neurology, Jena University Hospital, 07747 Jena, GermanyDepartment of Neurology, Jena University Hospital, 07747 Jena, GermanyCenter for Clinical Studies, Jena University Hospital, 07747 Jena, GermanyDepartment of Neurology and Center for Healthy Ageing, Jena University Hospital, 07747 Jena, GermanyNonadherence is a growing issue in the treatment of Parkinson’s disease (PD). Many factors are known to influence nonadherence, but little is known about the influence of quality of life (QoL). Detailed clinical data were obtained from 164 patients with PD using the Parkinson’s Disease Questionnaire-39 (PDQ-39) and the German Stendal Adherence with Medication Score (SAMS). Descriptive statistics were used to identify reasons for nonadherence, and multivariable linear models were used to study associations between QoL and clinical parameters as well as nonadherence. Multivariate analysis of variance (MANOVA) and multivariate analysis of covariance (MANCOVA) were used to study the effect of the SAMS on PDQ domains and other medical covariates. The results showed that 10.4% (<i>n</i> = 17) of patients were fully adherent, 66.4% (<i>n</i> = 109) were moderately nonadherent, and 23.2% (<i>n</i> = 38) were nonadherent. Nonadherence was associated with male gender, lower Montreal Cognitive Assessment (MoCA) score, higher non-motor symptoms questionnaire (NMS-Quest) score, greater number of medications per day (an indicator of comorbidity), and higher Beck Depression Inventory (BDI) score. QoL was correlated with male gender, lower MoCA score, higher NMS-Quest score, more comorbidities, and higher BDI score, but was not correlated with nonadherence.https://www.mdpi.com/2076-3425/11/2/273nonadherenceParkinson’s diseaseunified Parkinson’s disease rating scaleGerman Stendal Adherence with Medication Scorequality of lifemotor impairment
spellingShingle Hannah M. Zipprich
Sarah Mendorf
Thomas Lehmann
Tino Prell
Self-Reported Nonadherence to Medication Is Not Associated with Health-Related Quality of Life in Parkinson’s Disease
Brain Sciences
nonadherence
Parkinson’s disease
unified Parkinson’s disease rating scale
German Stendal Adherence with Medication Score
quality of life
motor impairment
title Self-Reported Nonadherence to Medication Is Not Associated with Health-Related Quality of Life in Parkinson’s Disease
title_full Self-Reported Nonadherence to Medication Is Not Associated with Health-Related Quality of Life in Parkinson’s Disease
title_fullStr Self-Reported Nonadherence to Medication Is Not Associated with Health-Related Quality of Life in Parkinson’s Disease
title_full_unstemmed Self-Reported Nonadherence to Medication Is Not Associated with Health-Related Quality of Life in Parkinson’s Disease
title_short Self-Reported Nonadherence to Medication Is Not Associated with Health-Related Quality of Life in Parkinson’s Disease
title_sort self reported nonadherence to medication is not associated with health related quality of life in parkinson s disease
topic nonadherence
Parkinson’s disease
unified Parkinson’s disease rating scale
German Stendal Adherence with Medication Score
quality of life
motor impairment
url https://www.mdpi.com/2076-3425/11/2/273
work_keys_str_mv AT hannahmzipprich selfreportednonadherencetomedicationisnotassociatedwithhealthrelatedqualityoflifeinparkinsonsdisease
AT sarahmendorf selfreportednonadherencetomedicationisnotassociatedwithhealthrelatedqualityoflifeinparkinsonsdisease
AT thomaslehmann selfreportednonadherencetomedicationisnotassociatedwithhealthrelatedqualityoflifeinparkinsonsdisease
AT tinoprell selfreportednonadherencetomedicationisnotassociatedwithhealthrelatedqualityoflifeinparkinsonsdisease